Trial intelligence / Profile preview

Bioequivalence Study of Donepezil HCl 10 mg Orodispersible Tablets in Healthy Thai Volunteers

TCTR20230628002Phase 1Unknown

Sponsor
International Bio Service
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of donepezil in Alzheimer's disease (AD) (2 arms), sponsored by International Bio Service. Status: unknown.

02

Drugs

donepezil
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on TCTR20230628002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230628002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call